Evidence map›Paper›PMID 39169153›Full record

ArticleScientific reports2024

Rational design of environmentally responsive antibodies with pH-sensing synthetic amino acids.

Yuya Isoda, Kazumasa Ohtake, Wen Piao, Taiji Oashi, Fumika Kiku, Aiko Uchida, Masahiro Ikeda, Kazuhiro Masuda, Kensaku Sakamoto, Yasuhisa Shiraishi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuya Isoda *Research Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Kazumasa Ohtake *Division of Structural and Synthetic Biology, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Wen PiaoResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Taiji OashiResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Fumika KikuResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Aiko UchidaResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Masahiro IkedaResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Kazuhiro MasudaResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan.
Kensaku SakamotoDivision of Structural and Synthetic Biology, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan. mnm5u.sakamoto@gmail.com.
Yasuhisa ShiraishiResearch Division, Kyowa Kirin Co. Ltd, Tokyo, 100-0004, Japan. yasuhisa.shiraishi.wj@kyowakirin.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are widely used as therapeutic agents to tackle various diseases. In the present study, to enhance their clinical values, we rationally designed pH-responsivity by exploiting the idiosyncratic protonation/deprotonation profiles of non-natural amino acids. 3-Nitro-L-tyrosine, 3-cyano-L-tyrosine, and 3, 5-halogenated-L-tyrosine, each with near neutral pK

Indexed as

Amino AcidsImmunoglobulin Fab FragmentsAnimalsAntibodiesDrug DesignHumansHydrogen-Ion ConcentrationStatic ElectricityTyrosineAmino AcidsAntibodiesImmunoglobulin Fab FragmentsTyrosine

Identifiers

PMID39169153
PMCPMC11339442

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.